PYQ Vault

NEET Zoology · Biotechnology and its Applications

Biotechnology in Medicine

How human insulin is made in E. coli and why the C peptide matters, how gene therapy treats ADA deficiency, and which methods find a disease before its symptoms show.

Why this matters

Ten NEET questions: four on insulin, three on gene therapy for ADA deficiency and three on molecular diagnosis. The C peptide was asked in 2021 and 2022, and Eli Lilly's bacterium in 2025. The gene therapy questions are from 2021 and 2022 and the diagnosis questions from 2021 to 2023; ADA deficiency came back in two 2024 match questions.

Concept 1 of 3: Genetically engineered insulin

Insulin is a small protein of two chains, A and B, held together by disulphide bridges. The body first makes it as a longer pro-hormone with an extra piece, the C peptide, which is cut out to give mature insulin. Insulin taken from cattle and pigs gave some patients allergies. So Eli Lilly made the A and B chains separately in E. coli and joined them, skipping the C peptide altogether.

Definition

Insulin, as NCERT gives it:

  • Adult-onset diabetes is managed by taking insulin at regular intervals.
  • Insulin was earlier extracted from the pancreas of slaughtered cattle and pigs. Insulin from an animal source caused some patients to develop allergy or other reactions to the foreign protein.
  • Insulin has two short polypeptide chains, A and B, linked by disulphide bridges.
  • In mammals, including humans, insulin is made as a pro-hormone that contains an extra stretch called the C peptide. Like a pro-enzyme, the pro-hormone must be processed before it becomes a mature, functional hormone.
  • The C peptide is not present in mature insulin: it is removed during maturation.
  • The main challenge for making insulin by rDNA techniques was getting insulin assembled into a mature form.
  • In 1983, Eli Lilly, an American company, prepared two DNA sequences for the A and B chains of human insulin and introduced them into the plasmids of E. coli. The chains were produced separately, extracted and combined by creating disulphide bonds to form human insulin.
  • Insulin is a protein, so a dose swallowed by mouth would be digested in the gut like any other protein (NEET 2025 asked why it is not given orally).
  • Recombinant therapeutics do not cause the unwanted immune responses common with similar products from non-human sources.
Form of insulinHas the C peptide?Note
Pro-hormone (pro-insulin)YesMust be processed into the mature hormone
Mature insulinNoA and B chains joined by disulphide bridges
Insulin made by rDNA technologyNoA and B chains made separately in E. coli, then joinedQ
NEET 2025: Eli Lilly used a bacterium (E. coli), not yeast, a virus or a phage.
Practise this conceptself-check · 5 quick reps

The same idea in a real exam question:

NEET · 2021 · NEET (UG) 2021 — 12 Sep 2021 · Q160Moderate

Example 1 · Biotechnology and its Applications · Biotechnology in Medicine

With regard to insulin choose correct options. (a) C-peptide is not present in mature insulin. (b) The insulin produced by rDNA technology has C-peptide. (c) The pro-insulin has C-peptide (d) A-peptide and B-peptide of insulin are interconnected by disulphide bridges. Choose the correct answer from the options given below

Engineered insulin has no C peptide

The pro-hormone carries the C peptide; mature insulin does not. Eli Lilly made the A and B chains separately, so its insulin never had a C peptide. A statement that rDNA insulin has the C peptide is false.

Two chains, two genes

Eli Lilly prepared two DNA sequences, one for chain A and one for chain B, and made the chains separately before joining them with disulphide bonds. It did not make pro-insulin and process it.

Read what the statement is about

A statement set may ask only about genetically engineered insulin. Lines that are true of pro-insulin or of animal insulin (made in the pancreas, taken from cattle and pigs, causing allergy) do not describe the engineered product.

Concept 2 of 3: Gene therapy for ADA deficiency

Some children are born without a working gene for the enzyme adenosine deaminase (ADA), which the immune system needs. Gene therapy gives the body a normal copy of the gene. In the first trial, white blood cells (lymphocytes) were taken out, given the gene and put back. These cells do not live forever, so the treatment must be repeated. Putting the gene into early embryonic cells could cure it for good.

Definition

Gene therapy, as NCERT gives it:

  • Gene therapy is a collection of methods that allows correction of a gene defect diagnosed in a child or embryo. Genes are inserted into a person's cells and tissues to treat a disease.
  • Correction means delivering a normal gene into the person or embryo to take over the function of, and compensate for, the non-functional gene.
  • The first clinical gene therapy was given in 1990 to a 4-year-old girl with adenosine deaminase (ADA) deficiency.
  • The ADA enzyme is crucial for the immune system to work. The disorder is caused by deletion of the gene for adenosine deaminase.
  • In some children it can be cured by bone marrow transplantation; in others it is treated by enzyme replacement therapy (functional ADA given by injection). Neither approach is completely curative.
  • Gene therapy steps: lymphocytes from the patient's blood are grown in culture outside the body; a functional ADA cDNA is introduced into them using a retroviral vector; the cells are returned to the patient.
  • These cells are not immortal, so the patient needs periodic infusion of genetically engineered lymphocytes.
  • If the gene isolated from marrow cells producing ADA is introduced into cells at early embryonic stages, it could be a permanent cure.
Treatment for ADA deficiencyWhat is doneIs it a lasting cure?
Bone marrow transplantationNew marrow givenNot completely curative
Enzyme replacement therapyFunctional ADA injectedNot completely curative
Gene therapy in lymphocytesADA cDNA put into cultured lymphocytes by a retroviral vector, then returnedNo: the cells are not immortal, so infusions are repeated
Gene put into early embryonic cellsGene from ADA-producing marrow cells introduced at early embryonic stagesCould be a permanent cure
Practise this conceptself-check · 5 quick reps

The same idea in a real exam question:

NEET · 2022 · NEET (UG) 2022 — 17 Jul 2022 · Q183Moderate

Example 2 · Biotechnology and its Applications · Biotechnology in Medicine

In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because :

The reason is short-lived cells

Infusions are repeated because the engineered lymphocytes are not immortal. That the cells are grown in culture, or that a retroviral vector is used, is true but is not the reason.

ADA deficiency is an immune disorder

Without ADA the immune system does not work. It is not linked to Addison's disease, Parkinson's disease or digestion.

Only the embryonic route is permanent

Bone marrow transplantation, enzyme replacement and lymphocyte gene therapy are all not completely curative. Only introducing the gene at early embryonic stages could give a permanent cure.

Concept 3 of 3: Molecular diagnosis

A doctor usually suspects an infection only after symptoms appear, and by then the germs are already many. Molecular methods find a disease much earlier. PCR copies the germ's DNA or RNA until even a tiny amount can be seen. A labelled probe finds a gene by pairing with it. ELISA finds the germ's antigens or the antibodies made against it.

Definition

Molecular diagnosis, as NCERT gives it:

  • Early diagnosis and understanding the pathophysiology of a disease are important for effective treatment.
  • Conventional methods (serum and urine analysis) cannot detect a disease early.
  • Recombinant DNA technology, PCR and ELISA serve the purpose of early diagnosis.
  • A pathogen is usually suspected only after it has caused a symptom, when its concentration is already high.
  • PCR amplifies the nucleic acid of a bacterium or virus, so a very low concentration can be found before symptoms show. PCR is routinely used to detect HIV in suspected AIDS patients, to find mutations in genes in suspected cancer patients, and to identify many other genetic disorders.
  • Probe and autoradiography: a single-stranded DNA or RNA tagged with a radioactive molecule (the probe) is allowed to hybridise to its complementary DNA in a clone of cells, then detected by autoradiography. The clone with the mutated gene does not appear on the photographic film, because the probe has no complementarity with the mutated gene.
  • ELISA is based on antigen-antibody interaction. It detects infection by the presence of antigens (proteins, glycoproteins) or of antibodies made against the pathogen.
MethodWhat it detectsHow
Serum and urine analysisDisease, but lateConventional method; no early detection
PCRVery small amounts of a pathogen's nucleic acid; gene mutationsAmplifies the nucleic acid (used for HIV and suspected cancer)
Radioactive probe with autoradiographyA mutated geneThe mutated clone does not appear on the film, as the probe does not pair with itQ
NEET 2021: the mutated gene does not appear on the film because the probe has no complementarity with it.
ELISAAntigens of the pathogen, or antibodies against itAntigen-antibody interaction
Practise this conceptself-check · 5 quick reps

The same idea in a real exam question:

NEET · 2023 · NEET (UG) 2023 — 07 May 2023 · Q157Moderate

Example 3 · Biotechnology and its Applications · Biotechnology in Medicine

Which one of the following techniques does not serve the purpose of early diagnosis of a disease for its early treatment?

Serum and urine tests are not early tests

NCERT calls serum and urine analysis conventional methods that cannot give early detection. rDNA technology, PCR and ELISA can.

The mutated gene stays dark

The probe pairs only with the normal sequence. The clone with the mutated gene does not appear on the film, because the probe has no complementarity with it.

ELISA is antibodies, PCR is nucleic acid

ELISA works through antigen-antibody binding. PCR amplifies DNA or RNA and uses no antibodies. Options swap the two.

Summary — formulas & gotchas at a glance

A revision cheat-sheet for the formulas and gotchas above. Click any concept name to jump back to its full explanation.

Reference tables (3)

Genetically engineered insulin3 rows
Form of insulinHas the C peptide?Note
Pro-hormone (pro-insulin)YesMust be processed into the mature hormone
Mature insulinNoA and B chains joined by disulphide bridges
Insulin made by rDNA technologyNoA and B chains made separately in E. coli, then joinedQ
NEET 2025: Eli Lilly used a bacterium (E. coli), not yeast, a virus or a phage.
Gene therapy for ADA deficiency4 rows
Treatment for ADA deficiencyWhat is doneIs it a lasting cure?
Bone marrow transplantationNew marrow givenNot completely curative
Enzyme replacement therapyFunctional ADA injectedNot completely curative
Gene therapy in lymphocytesADA cDNA put into cultured lymphocytes by a retroviral vector, then returnedNo: the cells are not immortal, so infusions are repeated
Gene put into early embryonic cellsGene from ADA-producing marrow cells introduced at early embryonic stagesCould be a permanent cure
Molecular diagnosis4 rows
MethodWhat it detectsHow
Serum and urine analysisDisease, but lateConventional method; no early detection
PCRVery small amounts of a pathogen's nucleic acid; gene mutationsAmplifies the nucleic acid (used for HIV and suspected cancer)
Radioactive probe with autoradiographyA mutated geneThe mutated clone does not appear on the film, as the probe does not pair with itQ
NEET 2021: the mutated gene does not appear on the film because the probe has no complementarity with it.
ELISAAntigens of the pathogen, or antibodies against itAntigen-antibody interaction

Watch out for (9)

Test yourself on a real paper

Sit a past NEET paper, timed and marked the way the exam marks it. You see your score and every answer the moment you finish. Free to start.

Sit a NEET past paper